Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 10 - HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION › Section 333-010-0000 - Cancer Reporting Regulations: Definitions

Current through Register Vol. 63, No. 7, July 1, 2024
(1) "Active follow-up program" means a
			 program for a health care facility to determine, at least annually, information
			 including but not limited to the vital status of each case.
(2) "Admitted" means a rendering of any
			 service by the health care facility to a patient under the authority or
			 auspices of the facility's license under ORS
			 441.015,
			 including but not limited to routine admission to the hospital, admission to
			 the emergency room, or receiving services in an out-patient clinic.
(3) "Authority" means the Oregon Health
			 Authority.
(4) "Central cancer
			 registry" means the Oregon Health Authority, Public Health Division program
			 authorized to collect, receive, and maintain cancer data for the entire state
			 and which maintains the system by which the collected information is reported
			 to the Division.
(5) "Central
			 Cancer Registry Notification Form" means the form required for practitioners to
			 report a case of reportable cancer or reportable non-malignant
			 condition.
(6) "Certified tumor
			 registrar" means an individual who passes the certification examination and is
			 currently certified by the Council on Certification of the National Cancer
			 Registrars Association which provides the education and skills needed to fully
			 abstract a cancer case.
(7)
			 "Clinical laboratory" means a facility where microbiological, serological,
			 chemical, hematological, immunohematological, immunological, toxicological,
			 cytogenetical, exfoliative cytological, histological, pathological or other
			 examinations are performed on material derived from the human body, for the
			 purpose of diagnosis, prevention of disease or treatment of patients by
			 physicians, dentists and other persons who are authorized by license to
			 diagnose or treat humans.
(8) "Date
			 of diagnosis" means the date of initial diagnosis by a practitioner for the
			 cancer being reported.
(9)
			 "Division" means the Public Health Division of the Oregon Health
			 Authority.
(10) "First course of
			 treatment" means all methods of treatment recorded in the treatment plan and
			 administered to a person with a case of reportable cancer or reportable
			 non-malignant condition before disease progression or recurrence, as defined in
			 the American College of Surgeons Commission on Cancer Oncology Registry Data
			 Standards Manual that is for the current year of diagnosis.
(11) "Health care facility" means a hospital,
			 as defined in ORS
			 442.015,
			 or an ambulatory surgical center, as defined in ORS
			 442.015 or any other facility in which patients are diagnosed or provided treatment for
			 cancer or benign or borderline tumors of the brain and central nervous
			 system.
(12) "Health system cancer
			 registry" means a cancer registry maintained by a health system that includes
			 all reportable cancer cases occurring in the population served by the health
			 system, whether or not the cases are diagnosed or treated in the health
			 system's health care facilities.
(13) "OSCaR" means the Oregon State Cancer
			 Registry and has the same meaning as "central cancer registry".
(14) "Practitioner" means any person whose
			 professional license allows the person to diagnose or treat cancer
			 patients.
(15) "Quality control
			 system" means operational procedures by which the accuracy, completeness, and
			 timeliness of the information reported to OSCaR can be determined and
			 improved.
(16) "Reportable cancer"
			 means all malignant neoplasms including carcinoma in situ, except basal and
			 squamous cell carcinoma of the skin, carcinoma in situ of the cervix uteri, CIN
			 III (diagnosed on or after January 1, 1996), and PIN III (diagnosed on or after
			 January 1, 2001).
(17) "Reportable
			 Cancer Data Items List" means the list of variables for reportable cancers and
			 reportable non-malignant conditions reported by health care facilities
			 following the recommendations of the Centers for Disease Control and Prevention
			 National Program of Cancer Registries ("CDC-NPCR") and further defined by the
			 North American Association of Central Cancer Registries ("NAACCR") Data
			 Standards and Data Dictionary, available on the Oregon State Cancer Registry
			 website:
www.healthoregon.org/oscar
.
(18) "Reportable non-malignant condition"
			 means benign or borderline tumors of the brain (including the meninges and
			 intracranial endocrine structures) and central nervous system, diagnosed on or
			 after January 1, 2004.
(19)
			 "Reportable pre-malignant condition" means all high-grade squamous
			 intraepithelial lesion (CIN 2,3) and adenocarcinoma in situ (AIS) of the
			 uterine cervix, high-grade squamous intraepithelial lesion of the vagina and
			 vulva (VAIN 2,3/VIN 2,3), and high-grade squamous intraepithelial lesion (AIN
			 2,3) and carcinoma in situ of the anus.
(20) "Special study" means a
			 Division-sponsored project that explores a particular facet of cancer
			 incidence, morbidity, or mortality including, but not limited to, exploring
			 hypotheses of disease risk, treatment options or cancer control authorized
			 under ORS
			 432.520.
Statutory/Other Authority: ORS
				  432.500,
				  432.510  & 432.540
Statutes/Other Implemented: ORS
				  432.510,
				  432.520  & 432.540